[go: up one dir, main page]

GB202107203D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB202107203D0
GB202107203D0 GBGB2107203.8A GB202107203A GB202107203D0 GB 202107203 D0 GB202107203 D0 GB 202107203D0 GB 202107203 A GB202107203 A GB 202107203A GB 202107203 D0 GB202107203 D0 GB 202107203D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2107203.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Owlstone Medical Ltd
Original Assignee
Owlstone Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Owlstone Medical Ltd filed Critical Owlstone Medical Ltd
Priority to GBGB2107203.8A priority Critical patent/GB202107203D0/en
Publication of GB202107203D0 publication Critical patent/GB202107203D0/en
Ceased legal-status Critical Current

Links

GBGB2107203.8A 2021-05-20 2021-05-20 Formulation Ceased GB202107203D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2107203.8A GB202107203D0 (en) 2021-05-20 2021-05-20 Formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2107203.8A GB202107203D0 (en) 2021-05-20 2021-05-20 Formulation

Publications (1)

Publication Number Publication Date
GB202107203D0 true GB202107203D0 (en) 2021-07-07

Family

ID=76637782

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2107203.8A Ceased GB202107203D0 (en) 2021-05-20 2021-05-20 Formulation

Country Status (1)

Country Link
GB (1) GB202107203D0 (en)

Similar Documents

Publication Publication Date Title
GB202007546D0 (en) Formulation
CA3265980A1 (en) Upadacitinib formulation
IL307849A (en) Sotorasib formulation
GB202102636D0 (en) Formulation
IL308046A (en) Alpelisib formulation
GB202108165D0 (en) Formulation
GB202107439D0 (en) Formulation
GB202107203D0 (en) Formulation
PL4138585T3 (en) Aerosolisable formulation
GB202103970D0 (en) Formulation
GB202102408D0 (en) Formulation
GB202016274D0 (en) Formulation
GB202010573D0 (en) Formulation
IL305977A (en) Formulation comprising ceralasertib
GB202005340D0 (en) Formulation
GB202003048D0 (en) Formulation
GB2599912B (en) New formulation
GB202115303D0 (en) New formulation
GB202108181D0 (en) New formulation
GB2595301B (en) Novel Formulation
GB2595300B (en) Novel Formulation
GB2595453B (en) Novel Formulation
IL323027A (en) Formulation
GB202318884D0 (en) Formulation
GB202316857D0 (en) Cannabinoid-based formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)